Sökning: WFRF:(Linder J)
> Larsson Rolf >
The 19S Deubiquitin...
The 19S Deubiquitinase Inhibitor b-AP15 Is Enriched in Cells and Elicits Rapid Commitment to Cell Death
-
- Wang, Xin (författare)
- Karolinska Institutet
-
- Stafford, William (författare)
- Karolinska Institutet
-
- Mazurkiewicz, Magdalena (författare)
- Karolinska Institutet
-
visa fler...
-
- Fryknäs, Mårten (författare)
- Uppsala universitet,Cancerfarmakologi och beräkningsmedicin
-
Brjnic, Slavica (författare)
-
- Zhang, Xiaonan (författare)
- Karolinska Institutet
-
- Gullbo, Joachim (författare)
- Uppsala universitet,Cancerfarmakologi och beräkningsmedicin
-
- Larsson, Rolf (författare)
- Uppsala universitet,Cancerfarmakologi och beräkningsmedicin
-
- Arner, Elias S. J. (författare)
- Karolinska Institutet
-
- D'Arcy, Padraig (författare)
- Karolinska Institutet
-
- Linder, Stig (författare)
- Karolinska Institutet,Uppsala universitet,Cancerfarmakologi och beräkningsmedicin
-
visa färre...
-
(creator_code:org_t)
- 2014-04-08
- 2014
- Engelska.
-
Ingår i: Molecular Pharmacology. - : American Society for Pharmacology & Experimental Therapeutics (ASPET). - 0026-895X .- 1521-0111. ; 85:6, s. 932-945
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- b-AP15 [(3E, 5E)-3,5-bis[(4-nitrophenyl) methylidene]-1-(prop-2enoyl) piperidin-4-one] is a small molecule inhibitor of the ubiquitin specific peptidase (USP) 14/ubiquitin carboxyl-terminal hydrolase (UCH) L5 deubiquitinases of the 19S proteasome that shows antitumor activity in a number of tumor models, including multiple myeloma. b-AP15 contains an alpha,beta-unsaturated carbonyl unit that is likely to react with intracellular nucleophiles such as cysteine thiolates by Michael addition. We found that binding of b-AP15 to USP14 is partially reversible, and that inhibition of proteasome function is reversible in cells. Despite reversible binding, tumor cells are rapidly committed to apoptosis/cell death after exposure to b-AP15. We show that b-AP15 is rapidly taken up from the medium and enriched in cells. Enrichment provides an explanation of the stronger potency of the compound in cellular assays compared with in vitro biochemical assays. Cellular uptake was impaired by 30-minute pretreatment of cells with low concentrations of N-ethylmaleimide (10 mu M), suggesting that enrichment was thiol dependent. We report that in addition to inhibition of deubiquitinases, b-AP15 inhibits the selenoprotein thioredoxin reductase (TrxR). Whereas proteasome inhibition was closely associated with cell death induction, inhibition of TrxR was not. TrxR inhibition is, however, likely to contribute to triggering of oxidative stress observed with b-AP15. Furthermore, we present structure-activity, in vivo pharmacokinetic, and hepatocyte metabolism data for b-AP15. We conclude that the strong enrichment of b-AP15 in cells and a rapid commitment to apoptosis/cell death are factors that likely contribute to the strong antitumor activity of this compound.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Wang, Xin
-
Stafford, Willia ...
-
Mazurkiewicz, Ma ...
-
Fryknäs, Mårten
-
Brjnic, Slavica
-
Zhang, Xiaonan
-
visa fler...
-
Gullbo, Joachim
-
Larsson, Rolf
-
Arner, Elias S. ...
-
D'Arcy, Padraig
-
Linder, Stig
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Farmakologi och ...
- Artiklar i publikationen
-
Molecular Pharma ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet